ロード中...

Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats

Liraglutide, an acylated analog of glucagon-like peptide 1 (GLP-1), could improve glycemic control in diabetes. Moreover, endogenous opioid peptides play a role in blood sugar regulation. Since GLP-1 receptors are also expressed in extra-pancreatic tissues, this study investigates the effect of lira...

詳細記述

保存先:
書誌詳細
出版年:Pharmaceuticals (Basel)
主要な著者: Cheng, Kai-Chun, Li, Ying-Xiao, Shieh, Po-Chuen, Cheng, Juei-Tang, Hsu, Chia-Chen
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699724/
https://ncbi.nlm.nih.gov/pubmed/33233692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13110407
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!